Boston Scientific Retains Right To Absorb Reva Medical Under Equity Deal

Reva Medical's unique slide-and-lock bioabsorbable stent design has attracted equity investment from Boston Scientific, which previously expressed doubts about the viability of the biodegradable stent concept

More from Archive

More from Medtech Insight